SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGNX -- MacroGenics
MGNX 1.415-3.7%11:57 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (72)11/8/2017 4:19:28 AM
From: Miljenko Zuanic1 Recommendation

Recommended By
tuck

  Read Replies (1) of 188
 
<I am interested in knowing if 012 contributed the variable region to MGD013. Anybody know? TIA.>

One would think probably it is, but I would not see that as positive. Appears (so far, by doses levels in P1) that 012 is less potent than K or N. (???)

From pre-clinical 013 is (by magnitude of 10) more active than 012!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News